Browse drugs

…Introduction Infliximab (IFX) improves outcomes in Inflammatory Bowel Disease; however …

…. 2013;38(4):365–76.Clare DF, Alexander FC, Mike S. Accelerated infliximab infusions are safe and well tolerated in patients with inflamma…

…IBD patients in stable remission on combination therapy with IV IFX and TP can be safely switched to SC IFX without the need for co…

…isease (IBD) exhibit non-response to biologic therapies such as infliximab (IFX), underscoring the need for combination strategies. Ferrop…

…le therapeutic options, anti-TNFα monoclonal antibodies such as infliximab (IFX) and adalimumab (ADA) are widely used in moderate-to-sever…

… M, Green Z, Morris K. OC4 Discontinuation of premedication for infliximab infusions is well-tolerated, without adverse events, and cost-s…

…erval (33.3%) and to restart the drug (25.0%). In patients with ustekinumab, the main interventions were to shorten the dosing interval (55…

…hose receiving systemic corticosteroids (cs), 57.5% (n=61) with infliximab (IFX) and 83% (n=45) receiving topical steroids.No infections o…

…oprine proved ineffective in maintaining clinical remission and Infliximab was initiated. Due to ongoing symptoms her IFX dose was increas…

…re, limiting its utility. Janus kinase inhibitors, particularly upadacitinib, have shown promise in observational studies, but data remain l…

…z FP, Quera R, Simian D, Flores L, Figueroa C, Ibañez P, et al. Infliximab in inflammatory bowel disease. Is premedication necessary? Gast…